Badacz, R.; Przewłocki, T.; Pieniążek, P.; Rosławiecka, A.; Kleczyński, P.; Legutko, J.; Żmudka, K.; Kabłak-Ziembicka, A.
MicroRNA-134-5p and the Extent of Arterial Occlusive Disease Are Associated with Risk of Future Adverse Cardiac and Cerebral Events in Diabetic Patients Undergoing Carotid Artery Stenting for Symptomatic Carotid Artery Disease. Molecules 2022, 27, 2472.
https://doi.org/10.3390/molecules27082472
AMA Style
Badacz R, Przewłocki T, Pieniążek P, Rosławiecka A, Kleczyński P, Legutko J, Żmudka K, Kabłak-Ziembicka A.
MicroRNA-134-5p and the Extent of Arterial Occlusive Disease Are Associated with Risk of Future Adverse Cardiac and Cerebral Events in Diabetic Patients Undergoing Carotid Artery Stenting for Symptomatic Carotid Artery Disease. Molecules. 2022; 27(8):2472.
https://doi.org/10.3390/molecules27082472
Chicago/Turabian Style
Badacz, Rafał, Tadeusz Przewłocki, Piotr Pieniążek, Agnieszka Rosławiecka, Paweł Kleczyński, Jacek Legutko, Krzysztof Żmudka, and Anna Kabłak-Ziembicka.
2022. "MicroRNA-134-5p and the Extent of Arterial Occlusive Disease Are Associated with Risk of Future Adverse Cardiac and Cerebral Events in Diabetic Patients Undergoing Carotid Artery Stenting for Symptomatic Carotid Artery Disease" Molecules 27, no. 8: 2472.
https://doi.org/10.3390/molecules27082472
APA Style
Badacz, R., Przewłocki, T., Pieniążek, P., Rosławiecka, A., Kleczyński, P., Legutko, J., Żmudka, K., & Kabłak-Ziembicka, A.
(2022). MicroRNA-134-5p and the Extent of Arterial Occlusive Disease Are Associated with Risk of Future Adverse Cardiac and Cerebral Events in Diabetic Patients Undergoing Carotid Artery Stenting for Symptomatic Carotid Artery Disease. Molecules, 27(8), 2472.
https://doi.org/10.3390/molecules27082472
